These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 3888969)

  • 1. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy.
    Scharf MB; Brown D; Woods M; Brown L; Hirschowitz J
    J Clin Psychiatry; 1985 Jun; 46(6):222-5. PubMed ID: 3888969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy.
    Broughton R; Mamelak M
    Can J Neurol Sci; 1980 Feb; 7(1):23-31. PubMed ID: 7388696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group
    J Clin Sleep Med; 2005 Oct; 1(4):391-7. PubMed ID: 17564408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures.
    Scrima L; Hartman PG; Johnson FH; Hiller FC
    Biol Psychiatry; 1989 Aug; 26(4):331-43. PubMed ID: 2669980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials.
    Boscolo-Berto R; Viel G; Montagnese S; Raduazzo DI; Ferrara SD; Dauvilliers Y
    Sleep Med Rev; 2012 Oct; 16(5):431-43. PubMed ID: 22055895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging treatments for narcolepsy and its related disorders.
    Nishino S; Okuro M
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ
    Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of narcolepsy-cataplexy with nocturnal gamma-hydroxybutyrate.
    Broughton R; Mamelak M
    Can J Neurol Sci; 1979 Feb; 6(1):1-6. PubMed ID: 264152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric narcolepsy.
    Peterson PC; Husain AM
    Brain Dev; 2008 Nov; 30(10):609-23. PubMed ID: 18375081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients with narcolepsy-cataplexy treated with sodium oxybate (Xyrem).
    Alshaikh MK; Gacuan D; George S; Sharif M; Bahammam AS
    Clin Neuropharmacol; 2011; 34(1):1-4. PubMed ID: 21206362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium oxybate for cataplexy.
    Lemon MD; Strain JD; Farver DK
    Ann Pharmacother; 2006 Mar; 40(3):433-40; quiz 581-2. PubMed ID: 16507620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium oxybate in narcolepsy with cataplexy: Zurich sleep center experience.
    Poryazova R; Tartarotti S; Khatami R; Baumann CR; Valko P; Kallweit U; Werth E; Bassetti CL
    Eur Neurol; 2011; 65(3):175-82. PubMed ID: 21389728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current pharmacologic management of narcolepsy.
    Scharf MB; Fletcher KA; Jennings SW
    Am Fam Physician; 1988 Jul; 38(1):143-8. PubMed ID: 3293383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of sodium hydroxybutyrate in the treatment of narcolepsy].
    Iakhno NN; Murmazaev MS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(8):1232-5. PubMed ID: 4050239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narcolepsy and automatic behavior: a case report.
    Zorick FJ; Salis PJ; Roth T; Kramer M
    J Clin Psychiatry; 1979 Apr; 40(4):194-7. PubMed ID: 422531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb; 25(1):42-9. PubMed ID: 11833860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
    Huang YS; Guilleminault C
    Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings.
    Mamelak M; Scharf MB; Woods M
    Sleep; 1986; 9(1 Pt 2):285-9. PubMed ID: 3704454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.